DNA Form 144: proposed sale of 1,312 shares, $17,907.89 value

DNA filed a Form 144 notice for a proposed sale of 1,312 shares of Class A common stock with an aggregate market value of $17,907.89, with an approximate sale date of 10/21/2025 on the NYSE through Fidelity Brokerage Services LLC.

Accepted by SEC EDGAR 10/21/2025 - 01:59 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

DNA filed a Form 144 notice for a proposed sale of 1,312 shares of Class A common stock with an aggregate market value of $17,907.89, with an approximate sale date of 10/21/2025 on the NYSE through Fidelity Brokerage Services LLC.

The shares were acquired on 10/16/2025 via restricted stock vesting as compensation. In the past three months, Steve Coen sold 310 shares for gross proceeds of $3,842.79. Shares outstanding were 47,089,598; this is a baseline figure, not the amount being offered.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does DNA's Form 144 filing propose to sell?

A proposed sale of 1,312 Class A shares with an aggregate market value of $17,907.89.

When is the approximate sale date in the DNA Form 144?

The approximate sale date listed is 10/21/2025.

Which broker and exchange are listed for the proposed DNA sale?

Broker: Fidelity Brokerage Services LLC; Exchange: NYSE.

How were the DNA shares to be sold acquired?

They were acquired on 10/16/2025 via restricted stock vesting as compensation.

Were there recent sales by the filer related to DNA?

Yes. In the past three months, Steve Coen sold 310 shares for $3,842.79.

How many DNA shares are outstanding as referenced in the notice?

The notice lists 47,089,598 shares outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001977441
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Ginkgo Bioworks Holdings, Inc.
SEC File Number	001-40097
Address of Issuer	27 DRYDOCK AVENUE 8TH FLOOR BOSTON MASSACHUSETTS 02210
Phone	(877) 442-5362
Name of Person for Whose Account the Securities are To Be Sold	Coen Steven P.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1312	17907.89	47089598	10/21/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	10/16/2025	Restricted Stock Vesting	Issuer			1312	10/16/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Steve Coen 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	08/22/2025	310	3842.79

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	10/21/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Steve Coen
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)